This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Covid-19 Vaccine Development Tools Market

Market Insights on Covid-19 Vaccine Development Tools covering sales outlook, demand forecast & up-to-date key trends

Covid-19 Vaccine Development Tools Market By Technology, Application, End-use & Region - Forecast 2022 - 2032

Covid-19 Vaccine Development Tools Market Outlook (2022-2032)

[250 Pages Report] Newly-released Covid-19 Vaccine Development Tools industry analysis report by Future Market Insights shows that global sales of Covid-19 Vaccine Development Tools in 2021 was held at US$ 17.2 Bn. With 10.7%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Laboratory Technologies are expected to be the highest revenue generating type, accounting for an absolute dollar opportunity of nearly US$ 32.8 Bn during 2022 – 2032.

Attributes

Details

Covid-19 Vaccine Development Tools Market CAGR (2022-2032)

10.7%

Covid-19 Vaccine Development Tools Market Size (2022)

US$ 18.9 Bn

Covid-19 Vaccine Development Tools Market Size (2032)

US$ 51.6 Bn

Customize this Report

Let us know your requirement to get
100% FREE customization

Revenue of Covid-19 Vaccine Development Tools from 2020 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Covid-19 Vaccine Development Tools industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2020 to 2021, market value of the Covid-19 Vaccine Development Tools industry increased at around 9% CAGR, wherein, countries such as the U.S., UK, China, South Korea and Japan held significant share in the global market.

Owing to this, Covid-19 Vaccine Development Tools market is projected to grow at a CAGR of 10.7% over the coming 10 years.

  • The Covid-19 Vaccine Development Tools market reached a valuation of US$ 18.9 Bn in 2021 increased by 6% over the last year. Future Market Insights estimates that Covid-19 Vaccine Development Tools revenue will grow 2.7X from 2022 to 2032, reaching nearly US$ 51.6 Bn in 2032.
  • Laboratory Technology segment among technologies, is expected to grow at the highest rate of 10.7% CAGR.
  • Going by the country, US is expected to produce largest revenue of $12.8 Bn by 2032.
  • The market in APAC is projected to register highest growth of 10.7% in the coming ten years.

What Factors are leading Towards Growth of Covid-19 Vaccine Development Tools Market?

The industry is expected to maintain its growth in the following years, owing to a large influx of vaccine designers and manufacturers from around the world. Despite the rapid development and deployment of vaccines, the SARS-CoV-2 infection curve has only recently begun to level off, particularly in developed countries.

Several factors are contributing to the development of this market, including artificial intelligence's critical role in the COVID-19 vaccine race, an expanding pool of collaborations to expedite vaccine research and clinical trials, and rigorous funding initiatives by government and private entities. The current environment of expedited vaccine research and clinical trials has motivated collaboration among vaccine developers and industry players.

SARS-COV-2 variants began to appear in the vaccine market in 2020, necessitating recertification of the effectiveness of the first-generation vaccines that were designed for use in that development period.

Pharmaceutical firms are focusing on creating long-term solutions for the SARSCOPE-C disease, which is prompting manufactures such as Thermo Fisher Scientific Inc., Hamilton Company, Sartorius AG, Agilent Technologies, and Bio-Rad Laboratories Inc. to expand their tool portfolio that is used only in the development of the vaccine for COVID-19.

AI has enormous potential to facilitate and revolutionise the discovery of innovative COVID-19 vaccines. AI is expected to play an important role in the development of vaccines for emerging coronavirus variants, and entities operating in this market space are collaborating with vaccine developers to further expand the market. Nanotronics, for example, announced in April 2021 that it has partnered with various key COVID-19 vaccine developers to assist in the efficient management of data linked with COVID-19 vaccine development activities through the use of AI-based online tools.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Region is projected to Offer the Largest Opportunity for Covid-19 Vaccine Development Tools?

Asia Pacific region is expected to register the highest CAGR during the forecast period due to increased demand for Covid-19 Vaccine Development Tools in developing countries, especially India and China. This can be attributed to its high Covid-affected population.

The International Conference on Genomes, Synaptic RNAs, and Vaccines 2019 hosted more than 420 researchers affiliated with ten international and Chinese institutions, who explored cutting-edge genome sequencing, cells, interactions, and immune response methods. The use of advanced sequencing techniques in China enabled the identification of the COVID-19 genome sequence and allowed the speedy implementation of vaccines against SARS-CoV-2.Chinese researchers used next-generation sequencing, electron microscopy, flow cytometry, and other methods to conduct studies on the SARS-CoV-2 genome, viral structural analysis, and cell imaging.

Country-wise Analysis

Which Country Lies at the Centre-stage for Covid-19 Vaccine Development Tools Revenue?

U.S. accounts for nearly 28% of the global Covid-19 vaccine development tools market revenue. The growth in country’s market can be attributed to a variety of factors, including increased R&D activities, funding initiatives, presence of key players, rising COVID-19 cases, and a high population base receiving COVID-19 vaccine, among others. Furthermore, government initiatives promoting the development of a COVID-19 vaccine can be attributed to market growth. For example, the United States government launched Operation Warp Speed, a public-private collaboration for the development, production, and distribution of COVID-19 vaccines.

Monitoring the rate of mutation is critical for the development of an effective vaccine against SARS-CoV-2. Companies in the United States are developing surveillance infrastructure to track SARS-CoV-2 mutations. Illumina, Inc. and Helix announced their collaboration to build a national surveillance infrastructure in the United States to monitor potential emergence and prevalence of novel SARS-CoV-2 strains in January 2021. Illumina's sequencing technology will be combined with Helix's nationwide testing footprint to expand security efforts established by the federal government for the early detection and evaluation of SARS-CoV-2 variants.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Country Lies at the Centre-stage for Covid-19 Vaccine Development Tools Revenue?

U.S. accounts for nearly 28% of the global Covid-19 vaccine development tools market revenue. The growth in country’s market can be attributed to a variety of factors, including increased R&D activities, funding initiatives, presence of key players, rising COVID-19 cases, and a high population base receiving COVID-19 vaccine, among others. Furthermore, government initiatives promoting the development of a COVID-19 vaccine can be attributed to market growth. For example, the United States government launched Operation Warp Speed, a public-private collaboration for the development, production, and distribution of COVID-19 vaccines.

Monitoring the rate of mutation is critical for the development of an effective vaccine against SARS-CoV-2. Companies in the United States are developing surveillance infrastructure to track SARS-CoV-2 mutations. Illumina, Inc. and Helix announced their collaboration to build a national surveillance infrastructure in the United States to monitor potential emergence and prevalence of novel SARS-CoV-2 strains in January 2021. Illumina's sequencing technology will be combined with Helix's nationwide testing footprint to expand security efforts established by the federal government for the early detection and evaluation of SARS-CoV-2 variants.

Category-wise Insights

Why Laboratories Technology Stands as the Revenue Base for Covid-19 Vaccine Development?

The laboratory technologies segment dominates the market, accounting for over 95% of total revenue. The use of laboratory technologies to grow the potency of vaccines, including polymerase chain reaction, cell culture, hemagglutination, flow cytometry, and spectrometry, is anticipated to favor the growth and delivery of vaccine diagnostic segments over the next five years. PCR and qPCR will constitute the most noteworthy revenue of the laboratory technologies industry in 2020. The broad use of PCR technologies in vaccine surveillance and efficacy testing has led to the industry's rapid expansion.

Medical professionals are also working to bring technologies like vaccine trackers and optimize management systems online. These tools are largely being employed by established companies to conduct research and development activities. Between mid-November 2020 and the present, Vaccine Predictor, a website, has been available online. This tool enables users to evaluate the CDC's recently updated vaccine portfolio and generate development timelines, according to Research and development activities.

Why Vaccine Research Segment Dominates Revenue among Applications?

The vaccine research segment dominated the market, accounting for around 44% of revenue. Several factors, including increased government funding, extensive research by universities and healthcare organisations, and increased business development strategies by prominent pharmaceutical companies, are driving the segment's growth. Furthermore, the segment's growth can be attributed to ongoing research activities aimed at improving the vaccine planning process.

For example, Stanford University researchers are working on developing a single-dose coronavirus vaccine that could potentially be stored at room temperature in January 2021. This could potentially help to reduce the cost of vaccine storage and transportation. Furthermore, for COVID-19 target discoveries, companies are increasingly engaging in business growth strategies such as agreements, alliances, and collaborations.

A new webtool based on the COVID-19 Vaccine Predictor was released in November 2020. This webtool allows users to explore an updated vaccine portfolio and evaluate the timeline for Research and development activities. Scientists collaborated to determine diagnosing and treating infectious diseases during this study to discover useful biomarkers to monitor at-risk individuals. These valuable insights helped to lead to a vaccine against COVID-19.

Competitive Analysis

The key players in Covid-19 vaccine development tools market include Thermo Fisher Scientific, Inc., Celerion, Cole-Parmer Instrument Company, LLC, Pfizer Inc., Sartorius AG, STEMCELL Technologies Inc., AB Sciex Pte. Ltd., Illumina, Inc., Agilent Technologies, and Bio-Rad Laboratories, Inc., among others.

Some of the recent developments of key Covid-19 Vaccine Development Tools providers are as follows:

  • In April 2021, Nanotronics announced that it has partnered with various key COVID-19 vaccine developers to assist in the efficient management of data linked with COVID-19 vaccine development activities through the use of AI-based online tools.
  • In February 2021, Pharmaceuticals business BioNTech extended its partnership with Merck KGaA to create a delay for the development of tools and technologies required for the production of mRNA-based vaccines for COVID-19. The strategic choice to extend the collaboration agreement with Merck is intended to increase the speed of mRNA-based vaccine production.
  • In January 2021, Illumina, Inc. and Helix joined forces to build a national surveillance infrastructure to monitor the onset and prevalence of novel SARS-CoV-2 strains in various parts of the U.S.
  • In October 2020, Sartorius AG will expand its presence in North America by opening a 40,000-square-foot Customer Engagement Center. The new Marlborough location will provide optimised factory user acceptance test and will be outfitted with new bioprocess equipment.

Similarly, recent developments related to companies offering Covid-19 Vaccine Development Tools have been tracked by the team at Future Market Insights, which are available in the full report.

Covid-19 Vaccine Development Tools Market Report Scope

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2020-2021

Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Latin America, Europe, Asia-Pacific, and MEA

Key Countries Covered

U.S., U.K., China, Japan, South Korea

Key Market Segments Covered

Technology, Application, End-Use

Key Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Celerion
  • Cole-Parmer Instrument Company, LLC.
  • Pfizer Inc.
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • AB Sciex Pte. Ltd.
  • Illumina, Inc.
  • Agilent Technologies
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Merck KGaA
  • Qiagen N.V.
  • Shimadzu Corporation
  • Eurofins Scientific
  • Charles River Laboratories
  • Takara Bio Inc.
  • PerkinElmer Inc.
  • Fluidigm
  • OLYMPUS CORPORATION
  • Avantor, Inc.
  • Polyplus Transfection
  • Hamilton Company
  • Aurora Biomed Inc.

Pricing

Available upon Request

Market Segments Covered in Covid-19 Vaccine Development Tools Industry Analysis

By Technology:

  • Laboratory Technologies
    • Next Generation Sequencing
    • PCR & qPCR
    • Flow Cytometry
    • Spectrometry
    • Microscopy & Electron Microscopy
    • Preparative & Process Chromatography
    • Nucleic Acid Isolation & Purification
    • Transfection Electroporation
    • Cell Culture
    • Automated Liquid Handling
  • Online Technologies
    • Interactive Web Technologies
    • Vaccine Management & Tracker Technologies

By Application:

  • Vaccine Research
  • Vaccine Process Development
  • Vaccine Quality Assurance/Quality Control

By End-use:

  • Pharma & Biopharma Companies
  • Contract Research Organization (CROs)
  • Academic & Research Institutes

Frequently Asked Questions

The global Covid-19 Vaccine Development Tools market is worth more than US$ 17.2 Bn at present.

Value of Covid-19 Vaccine Development Tools are projected to increase at a CAGR of around 10.7% during 2022 – 2032.

Value of Covid-19 Vaccine Development Tools increased at a CAGR of around 8.9% during 2020 – 2021.

The growing competition amongst the vaccine developers is one of the prominent market drivers for Covid-19 vaccine development tools market.

Top five players of Covid-19 Vaccine Development Tools market include Thermo Fisher Scientific Inc., Celerion, Cole-Parmer Instrument Company Llc., Pfizer, Sartorius AG

Top 5 countries driving demand for Covid-19 Vaccine Development Tools are U.S., U.K., China, Japan, South Korea

Asia Pacific accounted for around 40% of global Covid-19 Vaccine Development Tools demand in 2021.

The European market for Covid-19 Vaccine Development Tools is projected to expand at a CAGR of around 10% during 2022 – 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. FMI Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Covid-19 Vaccine Development Tools

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background 

    4.1. Covid-19 Vaccine Development Tools Market, by Key Countries

    4.2. Covid-19 Vaccine Development Tools Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch  Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Patch  Management Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Covid-19 Vaccine Development Tools Market Demand Analysis 2020-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2020-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Covid-19 Vaccine Development Tools Market Value Analysis 2020-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2020-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By Technology

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Technology, 2020-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        8.3.1. Laboratory Technologies

            8.3.1.1. Next Generation Sequencing

            8.3.1.2. PCR & qPCR

            8.3.1.3. Flow Cytometry

            8.3.1.4. Spectrometry

            8.3.1.5. Microscopy & Electron Microscopy

            8.3.1.6. Preparative & Process Chromatography

            8.3.1.7. Nucleic Acid Isolation & Purification

            8.3.1.8. Transfection Electroporation

            8.3.1.9. Cell Culture

            8.3.1.10. Automated Liquid Handling

        8.3.2. Online Technologies 

            8.3.2.1. Interactive Web Technologies

            8.3.2.2. Vaccine Management & Tracker Technologies

    8.4. Market Attractiveness Analysis By Technology

9. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2020-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        9.3.1. Vaccine Research

        9.3.2. Vaccine Process Development

        9.3.3. Vaccine Quality Assurance/Quality Control

    9.4. Market Attractiveness Analysis By Application

10. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By End-Use

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End-Use, 2020-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-Use, 2022-2032

        10.3.1. Pharma & Biopharma Companies

        10.3.2. Contract Research Organization (CROs)

        10.3.3. Academic & Research Institutes

    10.4. Market Attractiveness Analysis By End-Use

11. Global Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2020-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific 

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Technology

        12.4.3. By End-Use

        12.4.4. By Application

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Technology

        12.5.3. By End-Use

        12.5.4. By Application

13. Latin America Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Technology

        13.4.3. By End-Use

        13.4.4. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Technology

        13.5.3. By End-Use

        13.5.4. By Application

14. Europe Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Technology

        14.4.3. By End-Use

        14.4.4. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Technology

        14.5.3. By End-Use

        14.5.4. By Application

15. Asia Pacific Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Technology

        15.4.3. By End-Use

        15.4.4. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Technology

        15.5.3. By End-Use

        15.5.4. By Application

16. Middle East and Africa Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2020-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Technology

        16.4.3. By End-Use

        16.4.4. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Technology

        16.5.3. By End-Use

        16.5.4. By Application

17. Key Countries Covid-19 Vaccine Development Tools Market Analysis 2020-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Covid-19 Vaccine Development Tools Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.2.2.1. By Technology

            17.2.2.2. By End-Use

            17.2.2.3. By Application

    17.3. Canada Covid-19 Vaccine Development Tools Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.3.2.1. By Technology

            17.3.2.2. By End-Use

            17.3.2.3. By Application

    17.4. Mexico Covid-19 Vaccine Development Tools Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.4.2.1. By Technology

            17.4.2.2. By End-Use

            17.4.2.3. By Application

    17.5. Brazil Covid-19 Vaccine Development Tools Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.5.2.1. By Technology

            17.5.2.2. By End-Use

            17.5.2.3. By Application

    17.6. Germany Covid-19 Vaccine Development Tools Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.6.2.1. By Technology

            17.6.2.2. By End-Use

            17.6.2.3. By Application

    17.7. France Covid-19 Vaccine Development Tools Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.7.2.1. By Technology

            17.7.2.2. By End-Use

            17.7.2.3. By Application

    17.8. Italy Covid-19 Vaccine Development Tools Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.8.2.1. By Technology

            17.8.2.2. By End-Use

            17.8.2.3. By Application

    17.9. BENELUX Covid-19 Vaccine Development Tools Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.9.2.1. By Technology

            17.9.2.2. By End-Use

            17.9.2.3. By Application

    17.10. UK Covid-19 Vaccine Development Tools Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.10.2.1. By Technology

            17.10.2.2. By End-Use

            17.10.2.3. By Application

    17.11. Nordic Countries Covid-19 Vaccine Development Tools Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.11.2.1. By Technology

            17.11.2.2. By End-Use

            17.11.2.3. By Application

    17.12. China Covid-19 Vaccine Development Tools Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.12.2.1. By Technology

            17.12.2.2. By End-Use

            17.12.2.3. By Application

    17.13. Japan Covid-19 Vaccine Development Tools Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.13.2.1. By Technology

            17.13.2.2. By End-Use

            17.13.2.3. By Application

    17.14. South Korea Covid-19 Vaccine Development Tools Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.14.2.1. By Technology

            17.14.2.2. By End-Use

            17.14.2.3. By Application

    17.15. GCC Countries Covid-19 Vaccine Development Tools Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.15.2.1. By Technology

            17.15.2.2. By End-Use

            17.15.2.3. By Application

    17.16. South Africa Covid-19 Vaccine Development Tools Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.16.2.1. By Technology

            17.16.2.2. By End-Use

            17.16.2.3. By Application

    17.17. Turkey Covid-19 Vaccine Development Tools Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2020-2032

            17.17.2.1. By Technology

            17.17.2.2. By End-Use

            17.17.2.3. By Application

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies 

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive 

        19.3.1. Thermo Fisher Scientific, Inc

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Celerion

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Cole-Parmer Instrument Company, Llc.

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Pfizer

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Sartorius AG

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Stemcell Technologies Inc.

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. AB Sciex Pte. Ltd.

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Illumina, Inc.

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Eurofins Scientific

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Agilent Technologies

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

        19.3.11. Bio-Rad Laboratories, Inc.

            19.3.11.1. Overview

            19.3.11.2. Product Portfolio

            19.3.11.3. Sales Footprint

            19.3.11.4. Strategy Overview

        19.3.12. Danaher

            19.3.12.1. Overview

            19.3.12.2. Product Portfolio

            19.3.12.3. Sales Footprint

            19.3.12.4. Strategy Overview

        19.3.13. Merck KGaA

            19.3.13.1. Overview

            19.3.13.2. Product Portfolio

            19.3.13.3. Sales Footprint

            19.3.13.4. Strategy Overview

        19.3.14. Qiagen N.V.

            19.3.14.1. Overview

            19.3.14.2. Product Portfolio

            19.3.14.3. Sales Footprint

            19.3.14.4. Strategy Overview

        19.3.15. Shimadzu Corporation

            19.3.15.1. Overview

            19.3.15.2. Product Portfolio

            19.3.15.3. Sales Footprint

            19.3.15.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021

Table 2: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032

Table 3: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021

Table 4: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032

Table 5: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021

Table 6: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032

Table 7: Global Covid-19 Vaccine Development Tools Market, By Region, 2020 – 2021

Table 8: Global Covid-19 Vaccine Development Tools Market, By Region, 2022 – 2032

Table 9: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021

Table 10: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032

Table 11: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021

Table 12: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032

Table 13: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021

Table 14: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032

Table 15: North America Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021

Table 16: North America Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032

Table 17: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021

Table 18: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032

Table 19: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021

Table 20: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032

Table 21: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021

Table 22: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032

Table 23: Latin America Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021

Table 24: Latin America Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032

Table 25: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021

Table 26: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032

Table 27: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021

Table 28: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032

Table 29: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021

Table 30: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032

Table 31: Europe Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021

Table 32: Europe Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032

Table 33: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021

Table 34: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032

Table 35: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021

Table 36: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032

Table 37: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021

Table 38: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032

Table 39: Asia Pacific Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021

Table 40: Asia Pacific Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032

Table 41: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2020 – 2021

Table 42: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Technology, 2022 – 2032

Table 43: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2020 – 2021

Table 44: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By End-Use, 2022 – 2032

Table 45: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2020 – 2021

Table 46: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn), By Application, 2022 – 2032

Table 47: MEA Covid-19 Vaccine Development Tools Market, By Country, 2020 – 2021

Table 48: MEA Covid-19 Vaccine Development Tools Market, By Country, 2022 – 2032

Table 49: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021

Table 50: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032

Table 51: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021

Table 52: Global Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021

Table 54: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032

Table 55: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 – 2021

Table 56: North America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021

Table 58: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032

Table 59: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021

Table 60: Latin America Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021

Table 62: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032

Table 63: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021

Table 64: Europe Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021

Table 66: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032

Table 67: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021

Table 68: Asia Pacific Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Technology, 2020 - 2021

Table 70: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By End-Use, 2022 – 2032

Table 71: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Application, 2020 - 2021

Table 72: MEA Covid-19 Vaccine Development Tools Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032

Figure 2: Global Covid-19 Vaccine Development Tools Market Absolute $ Historical Gain (2020 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032

Figure 4: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 5: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032

Figure 6: Global Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032

Figure 7: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032

Figure 8: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032

Figure 9: Global Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032

Figure 10: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 11: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032

Figure 12: Global Covid-19 Vaccine Development Tools Market Share, By Region, 2022 & 2032

Figure 13: Global Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global Covid-19 Vaccine Development Tools Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032

Figure 16: North America Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032

Figure 18: North America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 19: North America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032

Figure 20: North America Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032

Figure 21: North America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032

Figure 22: North America Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032

Figure 23: North America Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032

Figure 24: North America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 25: North America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032

Figure 26: North America Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032

Figure 30: Latin America Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032

Figure 32: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 33: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032

Figure 34: Latin America Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032

Figure 35: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032

Figure 36: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032

Figure 37: Latin America Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032

Figure 38: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 39: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032

Figure 40: Latin America Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032

Figure 41: Latin America Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032

Figure 44: Europe Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032

Figure 46: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 47: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032

Figure 48: Europe Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032

Figure 49: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032

Figure 50: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032

Figure 51: Europe Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032

Figure 52: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 53: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032

Figure 54: Europe Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032

Figure 55: Europe Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032

Figure 58: MEA Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032

Figure 60: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 61: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032

Figure 62: MEA Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032

Figure 63: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032

Figure 64: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032

Figure 65: MEA Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032

Figure 66: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 67: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032

Figure 68: MEA Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032

Figure 69: MEA Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Year-on-Year Growth, 2020-2032

Figure 72: Asia Pacific Covid-19 Vaccine Development Tools Market Absolute $ Opportunity Historical (2020 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By Technology, 2022 & 2032

Figure 74: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Technology – 2022-2032

Figure 75: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By Technology – 2022-2032

Figure 76: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By End-Use, 2022 & 2032

Figure 77: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By End-Use – 2022-2032

Figure 78: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By End-Use – 2022-2032

Figure 79: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By Application, 2022 & 2032

Figure 80: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 81: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By Application – 2022-2032

Figure 82: Asia Pacific Covid-19 Vaccine Development Tools Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific Covid-19 Vaccine Development Tools Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific Covid-19 Vaccine Development Tools Market Attractiveness Index, By Country – 2022-2032

Figure 85: US Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 87: US Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 88: US Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 89: Canada Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 91: Canada Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 92: Canada Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 93: Brazil Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 95: Brazil Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 96: Brazil Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 97: Mexico Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 99: Mexico Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 100: Mexico Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 101: Germany Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 103: Germany Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 104: Germany Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 105: U.K. Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 107: U.K. Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 108: U.K. Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 109: France Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 111: France Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 112: France Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 113: Italy Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 115: Italy Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 116: Italy Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 117: BENELUX Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 119: BENELUX Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 120: BENELUX Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 121: Nordic Countries Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 123: Nordic Countries Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 124: Nordic Countries Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 125: China Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 127: China Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 128: China Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 129: Japan Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 131: Japan Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 132: Japan Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 133: South Korea Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 135: South Korea Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 136: South Korea Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 137: GCC Countries Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 139: GCC Countries Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 140: GCC Countries Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 141: South Africa Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 143: South Africa Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 144: South Africa Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Figure 145: Turkey Covid-19 Vaccine Development Tools Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey Covid-19 Vaccine Development Tools Market Share, By Technology, 2021

Figure 147: Turkey Covid-19 Vaccine Development Tools Market Share, By End-Use, 2021

Figure 148: Turkey Covid-19 Vaccine Development Tools Market Share, By Application, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Needle-Free Vaccine Injectors Market

Published : August 2021

Healthcare

Americas COVID-19 Testing Market

Published : July 2021

Healthcare

Pediatric Vaccine Market

Published : December 2016

Healthcare

Meningococcal Vaccines Market

Published : December 2021

Google translate

Covid-19 Vaccine Development Tools Market